Expanding What Is Possible
Kyntra Bio (fibrogen.com) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 71st percentile of 13165 Healthcare brands.
Kyntra Bio is a biopharmaceutical company headquartered in San Francisco, United States, founded in 1993. It focuses on developing therapies for oncology and rare diseases, emphasizing scientific rigor and operational excellence. The company highlights its pipeline, clinical trials, culture, and strategy on its website, positioning itself as a patient-focused organization serving patients, healthcare providers, researchers, and clinical trial partners.
| Brand Name | Kyntra Bio |
|---|---|
| Domain | fibrogen.com |
| Industry | Healthcare |
| Founded | 1993 |
| Headquarters | San Francisco |
| Main Competitors | Genentech (84/100), Amgen (90/100), Vertex Pharmaceuticals (88/100), Alnylam Pharmaceuticals (87/100), BioMarin Pharmaceutical (84/100), Incyte (87/100), Gilead Sciences (81/100) |
Moz Domain Authority 44/100 vs category average 41 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,169,241 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Kyntra Bio has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Explore the Kyntra Bio site to learn about our oncology and rare disease therapies, pipeline highlights, clinical trials, culture, and company strategy" (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, YouTube; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Kyntra Bio?", Claude could not identify the brand as of October 2026. I don't recognize a company called "Kyntra Bio," and the website given (fibrogen.com) actually belongs to FibroGen, a biopharmaceutical company, so there seems to be a mismatch between the name and the domain provided.
When asked "Best brands similar to Kyntra Bio?", Claude would not surface Kyntra Bio as of October 2026. I can't confidently recommend a company I can't verify, especially given the inconsistency between the stated name and the associated website.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Kyntra Bio's main competitors in Healthcare: Genentech (84/100), Amgen (90/100), Vertex Pharmaceuticals (88/100), Alnylam Pharmaceuticals (87/100), BioMarin Pharmaceutical (84/100).
Sources: Brand Analyzer scan
Kyntra Bio has limited AI-search visibility, scoring 49/100 on Brand Analyzer's AI visibility composite (visibility 63, trust 29, recommendation 49). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Kyntra Bio official site
Kyntra Bio was founded in 1993. Kyntra Bio operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Kyntra Bio is headquartered in San Francisco. Kyntra Bio operates in the Healthcare category.
Sources: Wikidata
Kyntra Bio scores 49/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Kyntra Bio official site
Kyntra Bio is a biopharmaceutical company based in San Francisco, United States, founded in 1993. It develops therapies for oncology and rare diseases, describing itself as patient-focused and committed to scientific rigor and operational excellence.
Sources: Kyntra Bio official site
Kyntra Bio can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Kyntra Bio official site
Kyntra Bio researches and develops therapies targeting oncology and rare diseases. The company manages a pipeline of treatments, conducts clinical trials, and works with healthcare providers, researchers, and clinical trial partners to advance new treatment options for serious and life-threatening conditions.
Sources: Kyntra Bio official site
Kyntra Bio's therapies and programs are intended for patients with serious and life-threatening oncology and rare diseases. The company also engages healthcare providers, researchers, and clinical trial partners in its development and testing processes.
Sources: Kyntra Bio official site
Kyntra Bio scores 49/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Kyntra Bio has a limited AI-visibility profile at 49/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (63/100) and its weakest is trust (29/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #1,169,241 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check (October 2026), Claude could not identify Kyntra Bio from memory, confirming the gaps above.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Kyntra Bio: Fast&Up (80/100), Family Voices (80/100), FinnGen (80/100), Fisher House Foundation (80/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.